To see all protocols that comply with the WHO Essential Medicine List 
Safety alert
Inadvertent intrathecal administration of cytotoxic drugs not intended for this purpose can have FATAL outcomes. 
Australian Commission on Safety and Quality in Health Care.

Only health care professionals who have attained competency and are approved as per local institutional guidelines in intraventricular administration of antineoplastic drugs, and the recognition and management of complications should perform this procedure. 

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

22 Mar 2018